These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5338860)

  • 1. Positive contrast cerebral ventriculography using water-soluble media. Clinical evaluation of 102 procedures using methyglucamine iothalamate 60 per cent.
    Heimburger RF; Kalsbeck JE; Campbell RL; Mealey J
    J Neurol Neurosurg Psychiatry; 1966 Aug; 29(4):281-90. PubMed ID: 5338860
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of intracranial pressure of meglumine iothalamate ventriculography.
    Shaw MM; Miller JD; Steven JL
    J Neurol Neurosurg Psychiatry; 1975 Oct; 38(10):1022-6. PubMed ID: 1081586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seizures associated with the use of meglumine iothalamate 60 per cent in ventriculography.
    Picaza JA; Hunter SE; Lee L
    J Neurosurg; 1972 Apr; 36(4):474-80. PubMed ID: 4536861
    [No Abstract]   [Full Text] [Related]  

  • 4. Experiences with the technique and complications of meglumine iothalamate (Conray) ventriculography.
    Natelson SE; Sayers MP; Hunt WE
    J Neurol Neurosurg Psychiatry; 1972 Apr; 35(2):264-9. PubMed ID: 4537662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylglucamine iothalamate 60 per cent for cerebral ventriculography.
    Handa J; Handa H
    Am J Roentgenol Radium Ther Nucl Med; 1969 Nov; 107(3):631-6. PubMed ID: 5307917
    [No Abstract]   [Full Text] [Related]  

  • 6. Microscopic effects of meglumine iothalamate. Ventriculography in canines.
    Weems TD; Cashion EL; Cunningham DL
    Neuroradiology; 1977 May; 13(3):151-4. PubMed ID: 301255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEGLUMINE IOTHALAMATE 60 PER CENT AND SODIUM DIATRIZOATE 50 PER CENT. COMPARISON OF UROGRAPHIC QUALITY AND SIDE-EFFECTS.
    DOTTER CT; JUDKINS MP
    Radiology; 1964 Feb; 82():225. PubMed ID: 14115299
    [No Abstract]   [Full Text] [Related]  

  • 8. A study of acid-base balance of CSF in connection with positive ventriculography using water soluble contrast media (Conray).
    Tanji H; Takahashi M; Masu K; Kawaguchi Y; Abe H
    Fukushima J Med Sci; 1976 Mar; 22(1-2):49-63. PubMed ID: 1088413
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ventriculography and myeloradiooculography with iodized water-soluble contrast media].
    Reixach-Granés R; Betting LC
    Arq Neuropsiquiatr; 1975 Mar; 33(1):82-90. PubMed ID: 1080660
    [No Abstract]   [Full Text] [Related]  

  • 10. Positive contrast cerebral ventriculography using water soluble media. I. Animal studies.
    Heimburger RF; Campbell RL; Kalsbeck JE; Mealey J; Goodell CL
    Confin Neurol; 1966; 28(2):97-116. PubMed ID: 5298004
    [No Abstract]   [Full Text] [Related]  

  • 11. [Severe reactions caused by Conray-400 used in ventriculography and myelography].
    Li ZX
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Sep; 15(3):141-2. PubMed ID: 6983954
    [No Abstract]   [Full Text] [Related]  

  • 12. Meglumine iocarmate (Dimer-X) ventriculography.
    Van Dellen JR; Lipschitz R
    Clin Radiol; 1973 Oct; 24(4):449-52. PubMed ID: 4621055
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cerebral ventriculography with water soluble positive contrast medium (methylglucamine iothalamate)].
    Isamat F; Miranda AM; Bartumeus F
    Neurochirurgie; 1970 Dec; 16(7):577-85. PubMed ID: 4931885
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dimer-X ventriculography (author's transl)].
    Kamano S; Amano K; Hanamura T; Hatanaka H
    No Shinkei Geka; 1976 Nov; 4(11):1065-73. PubMed ID: 1087379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical and experimental study of meglumine iocarmate in the subarachnoid space: a complication of positive contrast ventriculography.
    Yonekawa Y; Nishikawa M; Egli M; Klaiber R
    Surg Neurol; 1976 Mar; 5(3):167-70. PubMed ID: 816023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventriculography with meglumine iothalamate.
    Guthkelch AN; Zierski J; Fernandez-Serrats AA; Chatterjee SP
    Neuroradiology; 1973 Sep; 6(1):32-8. PubMed ID: 4601753
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of complication rates of meglumine diatrizoate and meglumine iothalamate in cerebral angiography.
    Kricheff II; Chase NE
    Am J Roentgenol Radium Ther Nucl Med; 1967 Sep; 101(1):220-3. PubMed ID: 5341249
    [No Abstract]   [Full Text] [Related]  

  • 18. The comparison of the complication rates of meglumine iothalamate and sodium diatrizoate in cerebral angiography.
    Chase NE; Kricheff II
    Am J Roentgenol Radium Ther Nucl Med; 1965 Dec; 95(4):852-6. PubMed ID: 5846296
    [No Abstract]   [Full Text] [Related]  

  • 19. Positive contrast ventriculography: a comparison between methyglucamine iothalamate sixty per cent and diiodeophenyl undecylate.
    Siqueira EB; Arumugasamy N
    Surg Forum; 1970; 21():441-2. PubMed ID: 5315225
    [No Abstract]   [Full Text] [Related]  

  • 20. Positive contrast ventriculography--a comparison between Conray (methylglucamine lothalamate 60 per cent) and Pantopaque (di-iodophenyl undecylate).
    Siqueira EB; Arumugasamy N
    Neurochirurgia (Stuttg); 1972 Sep; 15(5):173-7. PubMed ID: 4342829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.